KalVista Pharmaceuticals, Inc.
KALV · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$183 | -$127 | -$93 | -$82 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $22 | $10 | $0 |
| Change in WC | $15 | $15 | $7 | -$12 |
| Other Non-Cash | $15 | -$0 | -$0 | $16 |
| Operating Cash Flow | -$153 | -$89 | -$75 | -$78 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$31 | -$189 | -$98 | -$137 |
| Inv. Sales/Matur. | $123 | $105 | $141 | $196 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | $91 | -$85 | $41 | $58 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $98 | $0 | $0 | $0 |
| Stock Issued | $62 | $97 | $57 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $54 | $2 | $0 |
| Financing Cash Flow | $160 | $151 | $58 | $2 |
| Forex Effect | $2 | -$1 | $1 | -$1 |
| Net Chg. in Cash | $100 | -$24 | $26 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32 | $56 | $31 | $51 |
| End Cash | $132 | $32 | $56 | $31 |
| Free Cash Flow | -$153 | -$90 | -$76 | -$79 |